Swedbank’s MaxCyte MXCT Stock Holding History

Swedbank’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,390,000	Closed	-$3.79M	–	690
2025 Q1	$3.79M	Sell	1,390,000 -210,000	-13%	-$828K	0.01%	569
2024 Q4	$6.66M	Hold	1,600,000	–	–	0.01%	521
2024 Q3	$6.22M	Hold	1,600,000	–	–	0.01%	515
2024 Q2	$6.27M	Hold	1,600,000	–	–	0.01%	499
2024 Q1	$6.7M	Hold	1,600,000	–	–	0.06%	366
2023 Q4	$7.52M	Hold	1,600,000	–	–	0.01%	472
2023 Q3	$4.99M	Hold	1,600,000	–	–	0.01%	503
2023 Q2	$7.34M	Hold	1,600,000	–	–	0.01%	464
2023 Q1	$7.92M	Buy	1,600,000 +100,000	+7%	+$492K	0.02%	447
2022 Q4	$8.19M	Buy	1,500,000 +100,000	+7%	+$613K	0.02%	446
2022 Q3	$9.1M	Buy	1,400,000 +700,000	+100%	+$3.9M	0.02%	426
2022 Q2	$3.31M	Buy	700,000 +300,000	+75%	+$1.48M	0.01%	557
2022 Q1	$2.8M	Buy	400,000 +50,000	+14%	+$341K	0.01%	597
2021 Q4	$3.67M	Buy	350,000 +130,000	+59%	+$1.4M	0.01%	592
2021 Q3	$2.69M	Buy	+220,000	New	+$3.32M	0.01%	616

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swedbank's MXCT Position: Q2 2025 in Review

Swedbank sold out of MaxCyte (MXCT) in Q2 2025, closing a stake of 1,390,000 shares — an estimated $3.79M sold.

Swedbank first reported a position in MXCT in Q3 2021 and held it in 15 quarters. The position peaked at $9.1M in Q3 2022. 120 funds tracked by Wall St. Rank hold MXCT as of Q2 2025.

Swedbank reported no remaining MaxCyte position as of Q2 2025 after selling out during the quarter.
Swedbank sold 1,390,000 MaxCyte shares in Q2 2025, an estimated $3.79M.
Swedbank first reported a position in MaxCyte in Q3 2021 and held it in 15 quarters.
Swedbank's MaxCyte position peaked at $9.1M in Q3 2022.
120 funds tracked by Wall St. Rank held MaxCyte as of Q2 2025.

Based on Swedbank's 13F filing for Q2 2025, filed 10 Jul 2025.